Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

The European Renal Association - European Dialysis and Transplant Association Registry Annual Report 2014: a summary.

Pippias M, Kramer A, Noordzij M, Afentakis N, Alonso de la Torre R, Ambühl PM, Aparicio Madre MI, Arribas Monzón F, Åsberg A, Bonthuis M, Bouzas Caamaño E, Bubic I, Caskey FJ, Castro de la Nuez P, Cernevskis H, de Los Ángeles Garcia Bazaga M, des Grottes JM, Fernández González R, Ferrer-Alamar M, Finne P, Garneata L, Golan E, Heaf JG, Hemmelder MH, Idrizi A, Ioannou K, Jarraya F, Kantaria N, Kolesnyk M, Kramar R, Lassalle M, Lezaic VV, Lopot F, Macario F, Magaz Á, Martín de Francisco AL, Martín Escobar E, Martínez Castelao A, Metcalfe W, Moreno Alia I, Nordio M, Ots-Rosenberg M, Palsson R, Ratkovic M, Resic H, Rutkowski B, Santiuste de Pablos C, Seyahi N, Fernanda Slon Roblero M, Spustova V, Stas KJF, Stendahl ME, Stojceva-Taneva O, Vazelov E, Ziginskiene E, Massy Z, Jager KJ, Stel VS.

Clin Kidney J. 2017 Apr;10(2):154-169. doi: 10.1093/ckj/sfw135. Epub 2017 Jan 16.

2.

Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus.

Kramer A, Pippias M, Stel VS, Bonthuis M, Abad Diez JM, Afentakis N, Alonso de la Torre R, Ambuhl P, Bikbov B, Bouzas Caamaño E, Bubic I, Buturovic-Ponikvar J, Caskey FJ, Castro de la Nuez P, Cernevskis H, Collart F, Comas Farnés J, Garcia Bazaga Mde L, De Meester J, Ferrer Alamar M, Finne P, Garneata L, Golan E, G Heaf J, Hemmelder M, Ioannou K, Kantaria N, Kolesnyk M, Kramar R, Lassalle M, Lezaic V, Lopot F, Macário F, Magaz A, Martín-Escobar E, Metcalfe W, Ots-Rosenberg M, Palsson R, Piñera Celestino C, Resić H, Rutkowski B, Santiuste de Pablos C, Spustová V, Stendahl M, Strakosha A, Süleymanlar G, Torres Guinea M, Varberg Reisæter A, Vazelov E, Ziginskiene E, Massy ZA, Wanner C, Jager KJ, Noordzij M.

Clin Kidney J. 2016 Jun;9(3):457-69. doi: 10.1093/ckj/sfv151. Epub 2016 Jan 31.

3.

Glomerular filtration rate-estimating equations for patients with advanced chronic kidney disease.

Evans M, van Stralen KJ, Schön S, Prütz KG, Stendahl M, Rippe B, Jager KJ; ERA-EDTA Registry; Swedish Renal Registry Collaboration.

Nephrol Dial Transplant. 2013 Oct;28(10):2518-26. doi: 10.1093/ndt/gft226. Epub 2013 Jul 30.

PMID:
23904399
4.

The increase in renal replacement therapy (RRT) incidence has come to an end in Sweden-analysis of variations by region over the period 1991-2010.

Qureshi AR, Evans M, Stendahl M, Prütz KG, Elinder CG.

Clin Kidney J. 2013 Jun;6(3):352-7. doi: 10.1093/ckj/sft032.

5.

p27Kip1 is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patients.

Stendahl M, Nilsson S, Wigerup C, Jirström K, Jönsson PE, Stål O, Landberg G.

Int J Cancer. 2010 Dec 15;127(12):2851-8. doi: 10.1002/ijc.25297.

6.

Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.

Borgquist S, Holm C, Stendahl M, Anagnostaki L, Landberg G, Jirström K.

J Clin Pathol. 2008 Feb;61(2):197-203. doi: 10.1136/jcp.2006.040378.

PMID:
18223096
7.

High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients.

Stendahl M, Rydén L, Nordenskjöld B, Jönsson PE, Landberg G, Jirström K.

Clin Cancer Res. 2006 Aug 1;12(15):4614-8.

8.

Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification.

Jirström K, Stendahl M, Rydén L, Kronblad A, Bendahl PO, Stål O, Landberg G.

Cancer Res. 2005 Sep 1;65(17):8009-16.

9.

Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response.

Rydén L, Stendahl M, Jonsson H, Emdin S, Bengtsson NO, Landberg G.

Breast Cancer Res Treat. 2005 Jan;89(2):135-43.

PMID:
15692755
10.

Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients.

Stendahl M, Kronblad A, Rydén L, Emdin S, Bengtsson NO, Landberg G.

Br J Cancer. 2004 May 17;90(10):1942-8.

Supplemental Content

Loading ...
Support Center